Overview
[Confidence Level: High] Hemastatx is a Swiss-Belgian biotechnology organization dedicated to treating severe and underserved bleeding disorders through the modulation of Von Willebrand Factor (VWF) degradation by targeting the enzyme.7
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.